👉👉👉Breaking news 💥 Deeply honored to be named an #MPNHero this year & to join our MPN community 👉Award Ceremony this evening! 🙏🏾 for this most wonderful honor !👏🏽 globenewswire.com/news-release/2… | #ASH22 Raajit Rampal, M.D.Ph.D. Ghaith Abu-Zeinah, MD MD Anderson Cancer Center CURE Today Ruben A. Mesa, MD #endcancer

Truly honored and grateful for receiving the MPN hero award CURE Today alongside inspiring patients, caregivers, clinicians, scientists Naveen Pemmaraju, MD Raajit Rampal, M.D.Ph.D. Andrew Kuykendall MD PedsHemeDoc . Also had the pleasure of meeting the very talented Vanessa Bayer !! Cancer Research & Treatment Fund #ASH22

Proud of Reem Chamseddine , WeillCornellQatar student for receiving ASH abstract achievement award on our research in #mpnsm highlighted Silver MPN Center below (abstract #1740) #ASH22 in NOLA

During its annual MPN Heroes® event, CURE® honored the contributions of individuals who have made a difference within the field of MPNs, such as Raajit Rampal, M.D.Ph.D. from Memorial Sloan Kettering Cancer Center, Naveen Pemmaraju, MD from MD Anderson Cancer Center and Ghaith Abu-Zeinah, MD from NewYork-Presbyterian. curetoday.com/view/cure-salu…

Honored and humbled, thanks again to #mpnsm patients, CURE Today Silver MPN Center

Ramadan Mubarak to all those who observe !!

‼️📣 New Publication Alert 📣‼️ Polycythemia vera: aspects of its current diagnosis and initial treatment, a paper by Dr. Silver and Ghaith Abu-Zeinah, MD is now available! Click here 👉 tandfonline.com/doi/full/10.10… #PV #MPNSM #CancerResearch

Was a great pleasure having Dr. Mullally give the Richard Silver professorship grand rounds Weill Cornell Medicine Silver MPN Center . We learned a ton on all things CHIP, MPN and latest & exciting Mullally Lab research. Thank you!

Thank you for hosting me! Hope your audience find it informative

There are more and better options for #MPN treatments than ever, and many potential new treatments in late-stage clinical trials. Read a treatment landscape summary HERE: mpnrf.info/3qNUbfA #2023BCAM #mpnsm Raajit Rampal, M.D.Ph.D. Ghaith Abu-Zeinah, MD Memorial Sloan Kettering Cancer Center Weill Cornell Leukemia

Our review is published online ⁦Blood Advances⁩ : patients w PV <60y of age, cytoRx esp w IFN is not so bad! So why isn’t it standard of care yet? Congratulations ⁦Reem Chamseddine,⁩ ⁦WeillCornellQatar⁩ students, ⁦Weill Cornell Medicine⁩ coauthors ashpublications.org/bloodadvances/…

Looking forward to standing next to the tallest poster board in history and chatting with Claire Harrison & Ruben A. Mesa, MD at the #ESHMPN2024 poster session about our international adult & pediatric collaborative project on transition of care for adolescents with MPNs #MPNSM

❤️ Honored to be included as a member of the #MPN team at Weill Department of Medicine NewYork-Presbyterian with Joseph M. Scandura, MD, PhD and Ghaith Abu-Zeinah, MD during last week's 16th International Congress in Myeloproliferative Neoplasms #MPNSM Heather Newton MME #CardioOnc

Good morning San Diego #ASH24 !!

The phase III HOPE-PMF trial will investigate the efficacy of interferon-based therapy, ropeginterferon alfa-2b, for early and lower-risk primary #myelofibrosis. Ghaith Abu-Zeinah, MD, of Weill Cornell Medicine, presented the study's design at #ASH24. 📚 Read more: buff.ly/3BFuy6g

Exciting data on ROPEG INFa2B in early mf at #EHA25 by Harry Gill, MD FRCP FRCPath! Excited to be co-leading the upcoming Phase III trial for these patients! PharmaEssentia Ghaith Abu-Zeinah, MD #MPNSM